Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002491145 | SCV002776554 | uncertain significance | Holt-Oram syndrome | 2021-08-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005056228 | SCV005701259 | uncertain significance | Aortic valve disease 2 | 2024-06-12 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 206 of the TBX5 protein (p.Phe206Leu). This variant is present in population databases (rs533581420, gnomAD 0.003%). This missense change has been observed in individual(s) with long QT and Brugada syndrome (PMID: 33576403). ClinVar contains an entry for this variant (Variation ID: 487603). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TBX5 protein function. Experimental studies have shown that this missense change affects TBX5 function (PMID: 33576403). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Lupski Lab, |
RCV000656176 | SCV000678370 | uncertain significance | Wolff-Parkinson-White pattern | 2017-07-14 | no assertion criteria provided | research | This variant was identified in an individual with Wolff-Parkinson-White syndrome |